Hugest Innovation Medical Technology Co., Ltd. (Hugest Medical), based in Guangming District, is developing minimally invasive neurosurgical and brain science devices through clinically driven innovation and global collaboration.

Founded in 2019, the national high-tech enterprise focuses on integrating research, development and manufacturing for brain science and pain medicine, aiming to reduce reliance on imported medical devices.

The company’s founder Xu Yong said its R&D model prioritizes clinical needs, supported by a nearly 50-member team spanning materials engineering, neurosurgery and smart sensing.

Key products include a disposable trigeminal neuralgia balloon compression device that enables minimally invasive treatment in about three minutes, and an integrated neurosurgical navigation system that provides millimeter-precision imaging guidance for tumor and lesion localization, designed to improve accessibility in lower-tier hospitals.

Hugest Medical operates a 5,000-square-meter facility covering full-cycle production from R&D to mass manufacturing, and has partnered with Germany’s ADEOR and Mevion Medical to align with international standards.

In collaboration with the First Affiliated Hospital of Guangzhou Medical University, the company is building clinical databases and training programs to standardize trigeminal neuralgia procedures and expand access to minimally invasive treatment.